세계의 경비 코르티코스테로이드 시장 보고서(2025년)

Intranasal corticosteroids are anti-inflammatory drugs administered through the nose to treat conditions like allergic rhinitis and nasal polyps. They work by reducing swelling, congestion, and mucus production in the nasal passages, thereby improving breathing and alleviating allergy symptoms.

The main categories of intranasal corticosteroids include prescription and over-the-counter drugs. Prescription intranasal corticosteroids are doctor-approved medications used to manage moderate to severe allergic rhinitis or chronic nasal inflammation, often favored for long-term or specialized treatment under medical guidance. These drugs are applied to treat allergic rhinitis, nasal polyps, sinusitis, and related conditions. They are distributed through various channels such as hospital pharmacies, retail pharmacies, online pharmacies, and others, and are utilized by a range of end users including hospitals, clinics, homecare settings, and healthcare providers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The intranasal corticosteroids market research report is one of a series of new reports from The Business Research Company that provides intranasal corticosteroids market statistics, including intranasal corticosteroids global market size, regional shares, competitors with intranasal corticosteroids market share, detailed intranasal corticosteroids market segments, market trends and opportunities, and any further data you may need to thrive in the intranasal corticosteroids industry. The intranasal corticosteroids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intranasal corticosteroids market size has grown strongly in recent years. It will grow from $6.29 billion in 2024 to $6.78 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. Growth during the historic period can be attributed to the rising prevalence of allergic rhinitis, an increasing incidence of chronic sinusitis, greater awareness of non-oral treatment options, expanded use in pediatric allergic conditions, and improved availability of over-the-counter intranasal products.

The intranasal corticosteroids market size is expected to see strong growth in the next few years. It will grow to $9.07 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. Growth in the forecast period is expected to be driven by an increasing focus on minimally invasive therapies, a rising incidence of allergic diseases linked to climate change, growing preference for self-administered treatments, wider adoption of combination intranasal therapies, and enhanced digital health support for allergy management. Key trends during this period include the integration of smart devices for dose monitoring, innovations in preservative-free nasal sprays, development of pediatric-friendly formulations, advancement of steroid-free adjunct therapies, and the incorporation of e-health platforms for treatment tracking.

The growing prevalence of allergic rhinitis is expected to drive the expansion of the intranasal corticosteroids market in the coming years. Allergic rhinitis is an allergic reaction that causes inflammation in the nasal passages, usually triggered by airborne allergens like pollen, dust mites, mold, or pet dander. This condition is becoming more common primarily due to increasing environmental pollution, which exposes people to allergens and irritants that provoke allergic responses in the nasal passages. Intranasal corticosteroids work by reducing inflammation in the nasal passages, alleviating symptoms such as sneezing, congestion, and runny nose. For example, in October 2023, the National Library of Medicine reported that allergic rhinitis affects over 400 million individuals globally, with prevalence rates ranging from 10% to 30% in adults and exceeding 40% in children. Therefore, the rise in allergic rhinitis cases is boosting the intranasal corticosteroid market.

Key players in the intranasal corticosteroids market are developing innovative formulations like nasal sprays to improve targeted drug delivery and enhance patient adherence. Nasal sprays administer liquid medication directly into the nose via a spray nozzle to treat allergies, congestion, or inflammation. They facilitate rapid drug absorption through the nasal mucosa, providing quick relief while minimizing systemic side effects. For instance, in March 2024, OptiNose Inc., a US pharmaceutical company, gained FDA approval for XHANCE, the first treatment specifically indicated for adults with chronic rhinosinusitis (CRS) without nasal polyps. This nasal spray features a unique exhalation delivery system that allows the medication to penetrate deeply into the nasal cavity, effectively managing CRS with or without nasal polyps in adults. Each spray delivers 93 mcg of fluticasone propionate, and the device works by having the user blow into a mouthpiece while simultaneously releasing the spray into the nostril, ensuring precise delivery and improved symptom relief.

In April 2023, SK Capital Partners LP, a US-based investment firm, acquired Apotex for an undisclosed sum. This acquisition aims to strengthen Apotex's global standing in affordable pharmaceuticals by supporting growth, enhancing operational efficiency, and fostering product innovation. Apotex Inc. is a Canada-based manufacturer of intranasal corticosteroid sprays.

Major players in the intranasal corticosteroids market are GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Haleon plc, Intas Pharmaceuticals Limited, Organon Pharma (UK) Limited, Sun Pharmaceutical Industries Ltd., Apotex Inc., Perrigo Company plc, Aurobindo Pharma Limited, Cipla Ltd., Hikma Pharmaceuticals plc, Zydus Lifesciences Ltd., Glenmark Pharmaceuticals Limited, OptiNose US Inc., Taro Pharmaceutical Industries Ltd., Maya Biotech Private Limited, AdvaCare Pharma USA, Lupin Ltd., Xenone Healthcare Private Limited.

North America was the largest region in the intranasal corticosteroids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in intranasal corticosteroids report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the intranasal corticosteroids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The intranasal corticosteroids market consists of sales of fluticasone propionate nasal spray, mometasone furoate nasal spray, budesonide nasal spray, beclomethasone dipropionate nasal spray, and triamcinolone acetonide nasal spray. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intranasal Corticosteroids Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intranasal corticosteroids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intranasal corticosteroids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intranasal corticosteroids market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Types: Prescribed Drugs; Over-The-Counter Drugs
• 2) By Application: Allergic Rhinitis; Nasal Polyps; Sinusitis; Other Applications
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channel
• 4) By End User: Hospitals; Clinics; Homecare; Healthcare Providers
• Subsegments:
• 1) By Prescribed Drugs: Fluticasone Propionate; Mometasone Furoate; Budesonide; Beclomethasone Dipropionate; Ciclesonide
• 2) By Over-The-Counter Drugs: Triamcinolone Acetonide; Fluticasone Furoate; Budesonide Over-The-Counter Drugs
• Companies Mentioned: GlaxoSmithKline plc; Teva Pharmaceutical Industries Ltd.; Sandoz Group AG; Haleon plc; Intas Pharmaceuticals Limited; Organon Pharma (UK) Limited; Sun Pharmaceutical Industries Ltd.; Apotex Inc.; Perrigo Company plc; Aurobindo Pharma Limited; Cipla Ltd.; Hikma Pharmaceuticals plc; Zydus Lifesciences Ltd.; Glenmark Pharmaceuticals Limited; OptiNose US Inc.; Taro Pharmaceutical Industries Ltd.; Maya Biotech Private Limited; AdvaCare Pharma USA; Lupin Ltd.; Xenone Healthcare Private Limited.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Intranasal Corticosteroids Market Characteristics

3. Intranasal Corticosteroids Market Trends And Strategies

4. Intranasal Corticosteroids Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Intranasal Corticosteroids Growth Analysis And Strategic Analysis Framework

• 5.1. Global Intranasal Corticosteroids PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Intranasal Corticosteroids Market Growth Rate Analysis
• 5.4. Global Intranasal Corticosteroids Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Intranasal Corticosteroids Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Intranasal Corticosteroids Total Addressable Market (TAM)

6. Intranasal Corticosteroids Market Segmentation

• 6.1. Global Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prescribed Drugs
• Over-The-Counter Drugs
• 6.2. Global Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Allergic Rhinitis
• Nasal Polyps
• Sinusitis
• Other Applications
• 6.3. Global Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other Distribution Channel
• 6.4. Global Intranasal Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Homecare
• Healthcare Providers
• 6.5. Global Intranasal Corticosteroids Market, Sub-Segmentation Of Prescribed Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fluticasone Propionate
• Mometasone Furoate
• Budesonide
• Beclomethasone Dipropionate
• Ciclesonide
• 6.6. Global Intranasal Corticosteroids Market, Sub-Segmentation Of Over-The-Counter Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Triamcinolone Acetonide
• Fluticasone Furoate
• Budesonide Over-The-Counter Drugs

7. Intranasal Corticosteroids Market Regional And Country Analysis

• 7.1. Global Intranasal Corticosteroids Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Intranasal Corticosteroids Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Intranasal Corticosteroids Market

• 8.1. Asia-Pacific Intranasal Corticosteroids Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Intranasal Corticosteroids Market

• 9.1. China Intranasal Corticosteroids Market Overview
• 9.2. China Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Intranasal Corticosteroids Market

• 10.1. India Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Intranasal Corticosteroids Market

• 11.1. Japan Intranasal Corticosteroids Market Overview
• 11.2. Japan Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Intranasal Corticosteroids Market

• 12.1. Australia Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Intranasal Corticosteroids Market

• 13.1. Indonesia Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Intranasal Corticosteroids Market

• 14.1. South Korea Intranasal Corticosteroids Market Overview
• 14.2. South Korea Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Intranasal Corticosteroids Market

• 15.1. Western Europe Intranasal Corticosteroids Market Overview
• 15.2. Western Europe Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Intranasal Corticosteroids Market

• 16.1. UK Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Intranasal Corticosteroids Market

• 17.1. Germany Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Intranasal Corticosteroids Market

• 18.1. France Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Intranasal Corticosteroids Market

• 19.1. Italy Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Intranasal Corticosteroids Market

• 20.1. Spain Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Intranasal Corticosteroids Market

• 21.1. Eastern Europe Intranasal Corticosteroids Market Overview
• 21.2. Eastern Europe Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Intranasal Corticosteroids Market

• 22.1. Russia Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Intranasal Corticosteroids Market

• 23.1. North America Intranasal Corticosteroids Market Overview
• 23.2. North America Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Intranasal Corticosteroids Market

• 24.1. USA Intranasal Corticosteroids Market Overview
• 24.2. USA Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Intranasal Corticosteroids Market

• 25.1. Canada Intranasal Corticosteroids Market Overview
• 25.2. Canada Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Intranasal Corticosteroids Market

• 26.1. South America Intranasal Corticosteroids Market Overview
• 26.2. South America Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Intranasal Corticosteroids Market

• 27.1. Brazil Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Intranasal Corticosteroids Market

• 28.1. Middle East Intranasal Corticosteroids Market Overview
• 28.2. Middle East Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Intranasal Corticosteroids Market

• 29.1. Africa Intranasal Corticosteroids Market Overview
• 29.2. Africa Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Intranasal Corticosteroids Market Competitive Landscape And Company Profiles

• 30.1. Intranasal Corticosteroids Market Competitive Landscape
• 30.2. Intranasal Corticosteroids Market Company Profiles
  • 30.2.1. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sandoz Group AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Haleon plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Intas Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis

31. Intranasal Corticosteroids Market Other Major And Innovative Companies

• 31.1. Organon Pharma (UK) Limited
• 31.2. Sun Pharmaceutical Industries Ltd.
• 31.3. Apotex Inc.
• 31.4. Perrigo Company plc
• 31.5. Aurobindo Pharma Limited
• 31.6. Cipla Ltd.
• 31.7. Hikma Pharmaceuticals plc
• 31.8. Zydus Lifesciences Ltd.
• 31.9. Glenmark Pharmaceuticals Limited
• 31.10. OptiNose US Inc.
• 31.11. Taro Pharmaceutical Industries Ltd.
• 31.12. Maya Biotech Private Limited
• 31.13. AdvaCare Pharma USA
• 31.14. Lupin Ltd.
• 31.15. Xenone Healthcare Private Limited.

32. Global Intranasal Corticosteroids Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Intranasal Corticosteroids Market

34. Recent Developments In The Intranasal Corticosteroids Market

35. Intranasal Corticosteroids Market High Potential Countries, Segments and Strategies

• 35.1 Intranasal Corticosteroids Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Intranasal Corticosteroids Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Intranasal Corticosteroids Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer